Company intelligence / Profile preview

Syrio Pharma

Aparecida de Goiânia, Goiás, Brazil

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Syrio Pharma is a Brazilian pharmaceutical company specializing in the development, manufacturing, and commercialization of generic and branded medications. Based in Aparecida de Goiânia, the company offers a diverse portfolio that includes analgesics, anti-inflammatories, and a comprehensive line of nutritional supplements under the Syrio Vit brand. Syrio operates a state-of-the-art manufacturing facility that complies with international quality standards and Good Manufacturing Practices (GMP). The company is a significant player in the Brazilian retail pharma market, focusing on expanding access to affordable healthcare solutions through a robust distribution network.

Therapeutic areas: ImmunologyNeurologyInfectious DiseasesMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Syrio Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syrio Pharma.

Explore the full profile